Filing Details
- Accession Number:
- 0001225208-24-002191
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-15 17:25:32
- Reporting Period:
- 2024-02-13
- Accepted Time:
- 2024-02-15 17:25:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1438538 | M. Catherine Szyman | One Edwards Way Irvine CA 92614 | Cvp, Critical Care | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-13 | 20,000 | $36.75 | 54,814 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-13 | 20,000 | $86.46 | 34,814 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-15 | 27,000 | $36.75 | 61,814 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-15 | 27,000 | $85.62 | 34,814 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2024-02-13 | 20,000 | $0.00 | 20,000 | $36.75 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2024-02-15 | 27,000 | $0.00 | 27,000 | $36.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,000 | 2018-05-11 | 2024-05-10 | No | 4 | M | Direct |
| 0 | 2018-05-11 | 2024-05-10 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $86.00 to $86.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $85.44 to $85.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
